OCTAHYDROPYRAZINODIAZANAPHTHYRIDINE DIONE COMPOUND AND CRYSTAL FORM THEREOF

Title:

OCTAHYDROPYRAZINODIAZANAPHTHYRIDINE DIONE COMPOUND AND CRYSTAL FORM THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/041059

Kind Code:

A1

Abstract:

The present invention relates to an octahydropyrazinodiazanaphthyridine dione compound and a crystal form thereof, and specifically relates to a compound as represented by formula (I) and a crystal form thereof.

More Like This:

WO/2007/007041	HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES
WO/2012/062704	PYRIDINE COMPOUNDS AND AZA ANALOGUES THEREOF AS TYK2 INHIBITORS
WO/2005/014540	CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT

Inventors:

ZHOU KAI (CN)
CHEN KEVIN X (CN)
HU BOYU (CN)
ZHOU CHUANJIE (CN)
WAN ZILU (CN)
CHEN SHUHUI (CN)

Application Number:

PCT/CN2022/119398

Publication Date:

March 23, 2023

Filing Date:

September 16, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MEDSHINE DISCOVERY INC (CN)

International Classes:

C07D403/14; A61K31/551; A61K31/553; A61P35/00; C07D413/14

Domestic Patent References:

WO2021197499A1	2021-10-07
WO2020239123A1	2020-12-03

Foreign References:

US20190343838A1	2019-11-14
US20190177338A1	2019-06-13

Attorney, Agent or Firm:

SHANGHAI BESHINING LAW OFFICE (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: OCCLUDER AND METHOD FOR MANUFACTURING OCCLUDER

Next Patent: DISPLAY VEHICLE WINDOW AND VEHICLE